Fair Value of Financial Instruments - Changes in Financial Liabilities (Details) - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended |
|---|---|---|
Sep. 30, 2022 |
Sep. 30, 2022 |
|
| Liabilities: | ||
| Beginning balance | $ 20,098 | |
| Additions | 0 | |
| Changes in fair value | (16,005) | |
| Settlements | 0 | |
| Ending balance | $ 4,093 | 4,093 |
| Private Warrants | ||
| Liabilities: | ||
| Beginning balance | 19,098 | |
| Additions | 0 | |
| Changes in fair value | (900) | (16,005) |
| Settlements | 0 | |
| Ending balance | 3,093 | 3,093 |
| Contingent Consideration | ||
| Liabilities: | ||
| Beginning balance | 1,000 | |
| Additions | 0 | |
| Changes in fair value | 0 | |
| Settlements | 0 | |
| Ending balance | $ 1,000 | $ 1,000 |
| X | ||||||||||
- Definition A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period. No definition available.
|
| X | ||||||||||
- Definition Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of purchases of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|